Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia

By sjmartinez • January 31, 2025

Luu T, Fan A, Shaw R, Dalal H, Adams J, Santarossa M, Reid G, Tsai S, Clark NM, Albarillo FS. Improved Clinical Outcomes with Appropriate Meropenem De-escalation in Patients with Febrile Neutropenia. J Glob Infect Dis. 2024 Dec 21;16(4):145-151. doi: 10.4103/jgid.jgid_192_23. PMID: 39886084; PMCID: PMC11775401.

Tags: Clostridioides difficile infection, empiric antibiotic therapy, Febrile neutropenia, Fellow, hematological disorders, Infectious Diseases, meropenem, Publications

Related Posts

Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity

Tsaktanis T, Ammon L, Lößlein L, Peter A, Vandrey O, Naumann UJ, Behne M, Cook LJ, Levy M, Yeaman MR, Bennett JL, Rothhammer V; Guthy-Jackson[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson[...]

Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle[...]